The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Oncolytic herpes simplex virus vectors for cancer virotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Martuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., & Coen, D. M. (1991) · Science · doi:10.1126/science.1851332 · Cited by 1,050
Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301205 · Cited by 976
Self-citationHeise, C., Sampson-Johannes, A., Williams, A., Mccormick, F., Von Hoff, D. D., & Kirn, D. H. (1997) · Nature Medicine · doi:10.1038/nm0697-639 · Cited by 940
Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas
Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D., & Martuza, R. L. (1995) · Nature Medicine · doi:10.1038/nm0995-938 · Cited by 822
Self-citationStojdl, D. F., Lichty, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., & Bell, J. C. (2000) · Nature Medicine · doi:10.1038/77558 · Cited by 815
Liu, B. L., Robinson, M., Han, Z.-Q., Branston, R. H., English, C., Reay, P., McGrath, Y., Thomas, S. K., Thornton, M., Bullock, P., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301885 · Cited by 803
Reovirus Therapy of Tumors with Activated Ras Pathway
Coffey, M. C., Strong, J. E., Forsyth, P. A., & Lee, P. W. K. (1998) · Science · doi:10.1126/science.282.5392.1332 · Cited by 750
Chou, J., Kern, E. R., Whitley, R. J., & Roizman, B. (1990) · Science · doi:10.1126/science.2173860 · Cited by 711
Rampling, R., Cruickshank, G., Papanastassiou, V, Nicoll, J., Hadley, D., Brennan, D., Petty, R., MacLean, A., Harland, J., McKie, E., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301184 · Cited by 598
Rodríguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., & Henderson, D. (1997) · PubMed · Cited by 584
Kirn, D., Martuza, R. L., & Zwiebel, J. (2001) · Nature Medicine · doi:10.1038/89901 · Cited by 502
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
Todo, T., Martuza, R. L., Rabkin, S. D., & Johnson, P. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101136398 · Cited by 465
Self-citationReplicative adenoviruses for cancer therapy
Alemany, R., Balagué, C., & Curiel, D. T. (2000) · Nature Biotechnology · doi:10.1038/77283 · Cited by 421
Chou, J., & Roizman, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3266 · Cited by 393
Goldstein, D. J., & Weller, S. K. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.196-205.1988 · Cited by 392
DeWeese, T. L., van der Poel, H. G., Li, S., Mikhak, B., Drew, R., Goemann, M., Hamper, U. M., DeJong, R., Detorie, N. A., Rodríguez, R., et al. (2001) · PubMed · Cited by 385
Coen, D. M., Kosz-Vnenchak, M., Jacobson, J. G., Leib, D. A., Bogard, C. L., Schaffer, P. A., Tyler, K. L., & Knipe, D. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4736 · Cited by 362
Kirn, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301377 · Cited by 349
Ikeda, K., Ichikawa, T., Wakimoto, H., Silver, J. S., Deisboeck, T. S., Finkelstein, D., Harsh, G. R., Louis, D. N., Bartus, R. T., Hochberg, F. H., et al. (1999) · Nature Medicine · doi:10.1038/11320 · Cited by 339
Parker, J. N., Gillespie, G. Y., Love, C. E., Randall, S., Whitley, R. J., & Markert, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040557897 · Cited by 332
Papanastassiou, V, Rampling, R., Fraser, M., Petty, R., Hadley, D., Nicoll, J., Harland, J., Mabbs, R., & Brown, M. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301664 · Cited by 328
Balfour, H. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401608 · Cited by 285
Driscoll, J. S. (2002) · Cited by 273
MacLean, A. R., Ul-Fareed, M., Robertson, L., Harland, J., & Brown, S. M. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-3-631 · Cited by 254
Meignier, B., Longnecker, R., & Roizman, B. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.3.602 · Cited by 248
Mineta, T., Rabkin, S. D., & Martuza, R. L. (1994) · PubMed · Cited by 240
Self-citationOncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1
Farassati, F., Yang, A.-D., & Lee, P. W. K. (2001) · Nature Cell Biology · doi:10.1038/35087061 · Cited by 236
Wickham, T. J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301115 · Cited by 236
Prodrug-activating systems in suicide gene therapy
Springer, C. J., & Niculescu-Duvaz, I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10001 · Cited by 229
Goldstein, D. J., & Weller, S. K. (1988) · Virology · doi:10.1016/0042-6822(88)90144-4 · Cited by 226
Mellerick, D. M., & Fraser', N. W. (1987) · Virology · doi:10.1016/0042-6822(87)90198-x · Cited by 209
The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors.
Roizman, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11307 · Cited by 206
Chambers, R., Gillespie, G. Y., Soroceanu, L., Andreansky, S., Chatterjee, S., Chou, J., Roizman, B., & Whitley, R. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1411 · Cited by 192
Hunter, W. D., Martuza, R. L., Feigenbaum, F., Todo, T., Mineta, T., Yazaki, T., Toda, M., Newsome, J. T., Platenberg, R. C., Manz, H. J., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6319-6326.1999 · Cited by 191
Self-citationWhitley, R. J., Kern, E. R., Chatterjee, S., Chou, J., & Roizman, B. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116527 · Cited by 188
Markert, J. M., Malick, A., Coen, D. M., & Martuza, R. L. (1993) · Neurosurgery · doi:10.1097/00006123-199304000-00016 · Cited by 187
In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.
Rogulski, K. R., Freytag, S. O., Zhang, K., Gilbert, J. D., Paielli, D. L., Kim, J. H., Heise, C. C., & Kirn, D. H. (2000) · PubMed · Cited by 178
Chase, M., Chung, R. Y., & Chiocca, E. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0598-444 · Cited by 178
Boviatsis, E., Park, J., Sena‐Esteves, M., Kramm, C. M., Chase, M., Efird, J. T., Wei, M., Breakefield, X. O., & Chiocca, E. A. (1994) · PubMed · Cited by 175
Balachandran, S., Porosnicu, M., & Barber, G. N. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3474-3479.2001 · Cited by 174
Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel.
Yu, D., Chen, Y., Dilley, J., Li, Y., Embry, M. G., Zhang, H., Nguyen, N. N. M., Amin, P., Oh, J., & Henderson, D. (2001) · PubMed · Cited by 173
Intralesional injection of herpes simplex virus 1716 in metastatic melanoma
MacKie, R. M., Stewart, B., & Brown, S. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04048-4 · Cited by 171
Chen, Y., DeWeese, T. L., Dilley, J., et al. (2001) · PubMed · Cited by 163
Toda, M., Martuza, R. L., Kojima, H., & Rabkin, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4457 · Cited by 161
Self-citationA herpesvirus genetic element which affects translation in the absence of the viral GADD34 function.
Mohr, I., & Gluzman, Y. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00853.x · Cited by 157
Meignier, B., Martin, B., Whitley, R. J., & Roizman, B. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.2.313 · Cited by 152
Cameron, J. M., McDougall, I., Marsden, H. S., Preston, V. G., Ryan, D. M., & Subak-Sharpe, J. H. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-10-2607 · Cited by 148
Li, Y., Yu, D., Chen, Y., Amin, P. R., Zhang, H., Nguyen, N., & Henderson, D. (2001) · PubMed · Cited by 147
Chen, Y., Yu, D., Charlton, D., & Henderson, D. (2000) · Human Gene Therapy · doi:10.1089/10430340050083289 · Cited by 143
Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation in Mice
Sundaresan, P., Hunter, W. D. G., Martuza, R. L., & Rabkin, S. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3832-3841.2000 · Cited by 140
Self-citationToda, M., Rabkin, S. D., & Martuza, R. L. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.15-2177 · Cited by 136
Self-citationAghi, M. K., Chou, T., Suling, K. M., Breakefield, X. O., & Chiocca, E. A. (1999) · PubMed · Cited by 135
Cytokine Gene Transfer Enhances Herpes Oncolytic Therapy in Murine Squamous Cell Carcinoma
Wong, R. J., Patel, S. G., Kim, S., et al. (2001) · Human Gene Therapy · doi:10.1089/10430340150218396 · Cited by 135
Toyoizumi, T., Mick, R., Abbas, A. E., Kang, E. H., Kaiser, L. R., & Molnar-Kimber, K. L. (1999) · Human Gene Therapy · doi:10.1089/10430349950016410 · Cited by 120
E1B-Deleted Adenovirus ( dl 1520) Gene Therapy for Patients with Primary and Secondary Liver Tumors
Habib, N. A., Sarraf, C., Mitry, R. R., et al. (2001) · Human Gene Therapy · doi:10.1089/10430340150218369 · Cited by 117
Chung, R. Y., Saeki, Y., & Chiocca, E. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7556-7564.1999 · Cited by 115
Yoon, S. S., Nakamura, H., Carroll, N. M., Bode, B. P., Chiocca, E. A., & Tanabe, K. K. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.2.301 · Cited by 110
Coukos, G., Makrigiannakis, A., Kang, E. H., Caparelli, D., Benjamin, I., Kaiser, L. R., Rubin, S. C., Albelda, S. Μ., & Molnar-Kimber, K. L. (1999) · PubMed · Cited by 108
Transcriptional targeting of herpes simplex virus for cell-specific replication
Miyatake, S., Iyer, A., Martuza, R. L., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5124-5132.1997 · Cited by 108
Heise, C. C., Lemmon, M. J., & Kirn, D. H. (2000) · PubMed · Cited by 100
Nakamura, H., Mullen, J. T., Chandrasekhar, S., Pawlik, T. M., Yoon, S. S., & Tanabe, K. K. (2001) · PubMed · Cited by 93
Todo, T., Martuza, R. L., Dallman, M. J., & Rabkin, S. D. (2001) · PubMed · Cited by 89
Self-citationThe Pathogenicity of Ribonucleotide Reductase-Null Mutants of Herpes Simplex Virus Type 1 in Mice
Yamada, Y., Kimura, H., Morishima, T., Daikoku, T., Maeno, K., & Nishiyama, Y. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.6.1091 · Cited by 86
Cancer Gene Therapy Using a Replication-Competent Herpes Simplex Virus Type 1 Vector
Yoon, S. S., Carroll, N. M., Chiocca, E. A., & Tanabe, K. K. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00009 · Cited by 86
Laquerre, S. G., Anderson, D. B., Stolz, D. B., & Glorioso, J. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9683-9697.1998 · Cited by 82
Coukos, G., Makrigiannakis, A., Montas, S., Kaiser, L. R., Toyozumi, T., Benjamin, I., Albelda, S. Μ., Rubin, S. C., & Molnar-Kimber, K. L. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700130 · Cited by 68
Coukos, G., Makrigiannakis, A., Kang, E. H., Rubin, S. C., Albelda, S. Μ., & Molnar-Kimber, K. L. (2000) · PubMed · Cited by 59
Petrowsky, H., Roberts, G. D., Kooby, D. A., Burt, B. M., Bennett, J., Delman, K. A., Stanziale, S. F., Delohery, T. M., Tong, W. P., Federoff, H. J., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7050-7058.2001 · Cited by 47
Therapeutic Efficacy of G207 in a Novel Peripheral Nerve Sheath Tumor Model
Mashour, G. A., Moulding, H. D., Chalavi, A., Khan, G., Rabkin, S. D., Martuza, R. L., Driever, P. H., & Kurtz, A. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7641 · Cited by 22
Self-citationReplication-Competent Herpes Simplex Virus Vectors for Cancer Therapy
Rabkin, S. D., & Driever, P. H. (2001) · KARGER eBooks · doi:10.1159/000061720 · Cited by 13
Self-citation
Cited by
GENE THERAPY: Twenty-First Century Medicine
Verma, I. M., & Weitzman, M. D. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 616
Wakimoto, H., Kesari, S., Farrell, C. J., Curry, W. T., Zaupa, C., Aghi, M., Kuroda, T., Stemmer-Rachamimov, A., Shah, K., Liu, T.-C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3886 · Cited by 361
Self-citationOncolytic viruses in cancer therapy
Vähä-Koskela, M. J. V., Heikkilä, J. E., & Hinkkanen, A. E. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.02.002 · Cited by 333
High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus
Anderson, B. D., Nakamura, T., Russell, S. J., & Peng, K.-W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0884 · Cited by 315
TRAIL on trial: preclinical advances in cancer therapy
Stuckey, D. W., & Shah, K. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.08.007 · Cited by 276
Metadata
- Authors
- Varghese, S., & Rabkin, S. D.
- Venue
- Cancer Gene Therapy
- Published
- 2002-11-22
- Volume
- 9
- Issue
- 12
- Pages
- 967-978
- ISSN
- 0929-1903 (ISSN-L)
- 1476-5500
- OpenAlex
- W2045415534
- Cited by
- 264
- References
- 71
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.